CACI Beat Estimates, but the Real Test Is Whether FY2027's $33.41 EPS Guide Holds Up

CACI beat estimates, but the stock reaction was muted

CACI delivered a strong quarter, but the market did not immediately reward it.

The company reported adjusted EPS of $8.91 beat consensus by 23.2%, while revenue also beat expectations. Management also issued adjusted EPS guidance for the upcoming financial year 2027 of $33.41 at the midpoint. Even so, the shares fell 2.0% to US$517 in the week after the report. That is the central tension for investors: the numbers looked strong, but the stock reaction suggested the market still wants more proof.

That skepticism is easier to understand when you look at the timeline. CACI will also issue detailed FY 2027 guidance when it reports fourth-quarter and full-year 2026 results on August 5. In other words, the $33.41 figure referenced in recent coverage is the target investors will now scrutinize more closely.

CACI is still trading 33.61% below the average analyst price target, so the longer-term bull case has not disappeared. What changed is the short-term message: a strong quarter alone was not enough to trigger a clear post-earnings move.

The operating picture looks real, but conversion still matters

The latest quarter was not just about one good earnings print. Q2 revenue of $2.71 billion, up 17.6% and backlog of $32 billion at quarter end, up 3.2% suggest demand is still there. That fits CACI's role as a defense, intelligence, and IT solutions provider to government customers.

Recent company updates also point to an active operating story. CACI said it was assessed "Awardable" for Department of War Work in the CDAO's Tradewinds Solutions Marketplace, and it recently named Dr. Dave Young as Executive Vice President and Chief Operating Officer. For investors, those are useful signs that the company remains engaged in priority government programs and is strengthening execution at the senior level.

Why the backlog case still has appeal

A large backlog does not guarantee revenue, but it does suggest customers have already invested time in defining problems and selecting vendors. For CACI, the key question is not whether demand exists in theory. It is whether that backlog, along with newer program opportunities, can convert into steady sales and margins over time.

The COO hire matters for that reason. In a company that depends on award timing, program delivery, and disciplined execution, operational strength can be as important as the headline demand story.

Why the market may still be hesitating

The caution is not necessarily about demand alone. It appears to be about how cleanly that demand turns into sustained earnings.

In an earlier quarter, book-to-bill fell to 0.65x, and the protracted government shutdown weighed on award timing. That does not prove the pipeline is weakening. It does suggest investors should be careful about treating backlog as guaranteed revenue.

There were also temporary supports. Adjusted diluted earnings per share of $6.81 were 14% higher than a year ago, helped in part by a lower share count. And the pending ARCA acquisition, excluded from guidance, is expected to lift leverage to 4.3 times at close before deleveraging over the next six quarters. That means the guidance profile is useful, but it is not a perfectly clean read on near-term quality.

The real debate: adjusted guidance versus consensus

After the latest results, sell-side forecasts now point to revenues of US$10.7b in 2027 and statutory per-share earnings are expected to be US$24.46, roughly flat on the last 12 months. That is different from management's adjusted EPS guidance for the upcoming financial year 2027 of $33.41 at the midpoint.

That gap is the real test. Bulls can point to a quality business with real government demand and a recent earnings beat. Bears will say the stock will work only if CACI can show that the higher adjusted EPS path is durable, not just a favorable accounting presentation for one year. For now, the market seems willing to wait for that proof.